USFDA :Lupin gets USFDA nod to market drug used to treat chronic hepatitis B
Drug agency Lupin on Monday stated it has obtained approval from the US well being regulator to market Tenofovir Alafenamide ...
Drug agency Lupin on Monday stated it has obtained approval from the US well being regulator to market Tenofovir Alafenamide ...
Copyright © 2022 Asia Today.